MetaADEDB 2.0 @ LMMD
rucaparib
(HMABYWSNWIZPAG-UHFFFAOYSA-N)
Structure
SMILES
CNCc1ccc(cc1)c1[nH]c2c3c1CCNC(=O)c3cc(c2)F
Type(s)
Approved; Investigational
ATC code(s)
L01XX55
Molecular Formula:
C19H18FN3O
Molecular Weight:
323.364
Log P:
3.6990
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
56.92
CAS Number(s):
283173-50-2
Synonym(s)
1.
rucaparib
2.
AG 014699
3.
AG-014699
4.
AG014699
5.
PF-01367338
External Link(s)
MeSHC531549
PubChem Compound9931954
BindingDB50446130
ChEBI134689
94311
CHEMBLCHEMBL1173055
DrugBankDB12332
DrugCentral5203
IUPHAR/BPS Guide to PHARMACOLOGY7736
KEGGdr:D10079
Therapeutic Target DatabaseD01SHZ
ZINC25958
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 1163US FAERS
2NauseaFAERS: 1153US FAERS
3Malignant neoplasm progressionFAERS: 513US FAERS
4DysgeusiaFAERS: 442US FAERS
5VomitingFAERS: 384US FAERS
6ConstipationFAERS: 332US FAERS
7Drug dose omissionFAERS: 309US FAERS
8AstheniaFAERS: 236US FAERS
9Abdominal PainFAERS: 180US FAERS
10HeadacheFAERS: 176US FAERS
11Drug ineffectiveFAERS: 164US FAERS
12DizzinessFAERS: 160US FAERS
13Adverse eventFAERS: 151US FAERS
14Prescribed underdoseFAERS: 150US FAERS
15MalaiseFAERS: 144US FAERS
16Product dose omissionFAERS: 137US FAERS
17White blood cell count decreasedFAERS: 135US FAERS
18Abdominal discomfortFAERS: 111US FAERS
19Weight decreasedFAERS: 93US FAERS
20Blood creatinine increasedFAERS: 90US FAERS
21PainFAERS: 81US FAERS
22Blood count abnormalFAERS: 80US FAERS
23PruritusFAERS: 79US FAERS
24Toxicity to various agentsFAERS: 79US FAERS
25DehydrationFAERS: 74US FAERS
26ThrombocytopeniaFAERS: 74US FAERS
27Back PainFAERS: 69US FAERS
28AnxietyFAERS: 63US FAERS
29FlatulenceFAERS: 61US FAERS
30ArthralgiaFAERS: 58US FAERS
31DyspepsiaFAERS: 55US FAERS
32NeutropeniaFAERS: 50US FAERS
33Accidental underdoseFAERS: 49US FAERS
34Dry skinFAERS: 49US FAERS
35NasopharyngitisFAERS: 49US FAERS
36Peripheral swellingFAERS: 49US FAERS
37Urinary tract infectionFAERS: 48US FAERS
38Unevaluable eventFAERS: 46US FAERS
39AlopeciaFAERS: 44US FAERS
40Feeling abnormalFAERS: 44US FAERS
41StomatitisFAERS: 41US FAERS
42InfluenzaFAERS: 40US FAERS
43Alanine Aminotransferase IncreasedFAERS: 39US FAERS
44SomnolenceFAERS: 38US FAERS
45MyalgiaFAERS: 36US FAERS
46SunburnFAERS: 35US FAERS
47Aspartate Aminotransferase IncreasedFAERS: 34US FAERS
48InfectionFAERS: 31US FAERS
49Therapy cessationFAERS: 31US FAERS
50Blood magnesium decreasedFAERS: 29US FAERS
51ChillsFAERS: 27US FAERS
52Intestinal ObstructionFAERS: 27US FAERS
53Febrile NeutropeniaFAERS: 26US FAERS
54Therapy partial responderFAERS: 26US FAERS
55SinusitisFAERS: 24US FAERS
56Blood glucose increasedFAERS: 23US FAERS
57Blood potassium decreasedFAERS: 23US FAERS
58Neutrophil count decreasedFAERS: 22US FAERS
59TremorFAERS: 22US FAERS
60AmnesiaFAERS: 21US FAERS
61Oropharyngeal painFAERS: 21US FAERS
62ErythemaFAERS: 20US FAERS
63HypersensitivityFAERS: 20US FAERS
64Joint swellingFAERS: 20US FAERS
65AscitesFAERS: 19US FAERS
66Early satietyFAERS: 19US FAERS
67Oral painFAERS: 19US FAERS
68Blood cholesterol increasedFAERS: 18US FAERS
69HypophagiaFAERS: 18US FAERS
70Incorrect dose administeredFAERS: 18US FAERS
71RetchingFAERS: 18US FAERS
72DysphoniaFAERS: 17US FAERS
73FlushingFAERS: 17US FAERS
74Memory impairmentFAERS: 17US FAERS
75PalpitationsFAERS: 17US FAERS
76Bone painFAERS: 16US FAERS
77Wrong technique in product usage processFAERS: 16US FAERS
78Depressed moodFAERS: 15US FAERS
79Night sweatsFAERS: 15US FAERS
80PneumoniaFAERS: 15US FAERS
81Blood alkaline phosphatase increasedFAERS: 14US FAERS
82Chest PainFAERS: 14US FAERS
83NervousnessFAERS: 14US FAERS
84ArthritisFAERS: 13US FAERS
85LymphadenopathyFAERS: 13US FAERS
86Product use in unapproved indicationFAERS: 13US FAERS
87Blood iron decreasedFAERS: 12US FAERS
88Chest discomfortFAERS: 12US FAERS
89HypersomniaFAERS: 12US FAERS
90Therapy changeFAERS: 12US FAERS
91BronchitisFAERS: 11US FAERS
92Burning sensationFAERS: 11US FAERS
93Musculoskeletal PainFAERS: 11US FAERS
94RestlessnessFAERS: 11US FAERS
95Drug ineffective for unapproved indicationFAERS: 10US FAERS
96EpistaxisFAERS: 10US FAERS
97EructationFAERS: 10US FAERS
98HypotensionFAERS: 10US FAERS
99Neck PainFAERS: 10US FAERS
100Productive CoughFAERS: 10US FAERS
101Respiratory tract congestionFAERS: 10US FAERS
102Accidental overdoseFAERS: 9US FAERS
103DysuriaFAERS: 9US FAERS
104Limb discomfortFAERS: 9US FAERS
105Poor quality sleepFAERS: 9US FAERS
106VertigoFAERS: 9US FAERS
107Abdominal tendernessFAERS: 8US FAERS
108Blood sodium decreasedFAERS: 8US FAERS
109CystitisFAERS: 8US FAERS
110LeukopeniaFAERS: 8US FAERS
111NeuralgiaFAERS: 8US FAERS
112PresyncopeFAERS: 8US FAERS
113Skin irritationFAERS: 8US FAERS
114TachycardiaFAERS: 8US FAERS
115Temperature intoleranceFAERS: 8US FAERS
116UrticariaFAERS: 8US FAERS
117Visual ImpairmentFAERS: 8US FAERS
118CataractFAERS: 7US FAERS
119ChromaturiaFAERS: 7US FAERS
120ColitisFAERS: 7US FAERS
121Feeling ColdFAERS: 7US FAERS
122Musculoskeletal chest painFAERS: 7US FAERS
123PancytopeniaFAERS: 7US FAERS
124Poor quality drug administeredFAERS: 7US FAERS
125SluggishnessFAERS: 7US FAERS
126SyncopeFAERS: 7US FAERS
127Throat irritationFAERS: 7US FAERS
128ArthropathyFAERS: 6US FAERS
129Blood urea increasedFAERS: 6US FAERS
130Cold sweatFAERS: 6US FAERS
131Loss of personal independence in daily activitiesFAERS: 6US FAERS
132MYELODYSPLASTIC SYNDROMEFAERS: 6US FAERS
133Musculoskeletal discomfortFAERS: 6US FAERS
134NoduleFAERS: 6US FAERS
135SneezingFAERS: 6US FAERS
136Viral upper respiratory tract infectionFAERS: 6US FAERS
137Cerebrovascular accidentFAERS: 5US FAERS
138Clostridium difficile infectionFAERS: 5US FAERS
139Drug prescribing errorFAERS: 5US FAERS
140Enzyme level increasedFAERS: 5US FAERS
141Flank PainFAERS: 5US FAERS
142GastritisFAERS: 5US FAERS
143Intentional product use issueFAERS: 5US FAERS
144LaryngitisFAERS: 5US FAERS
145Lower respiratory tract infectionFAERS: 5US FAERS
146Musculoskeletal stiffnessFAERS: 5US FAERS
147NephrolithiasisFAERS: 5US FAERS
148PancreatitisFAERS: 5US FAERS
149Paranasal sinus hypersecretionFAERS: 5US FAERS
150PharyngitisFAERS: 5US FAERS
151Platelet count abnormalFAERS: 5US FAERS
152Product storage errorFAERS: 5US FAERS
153Saliva alteredFAERS: 5US FAERS
154Solar dermatitisFAERS: 5US FAERS
155ToothacheFAERS: 5US FAERS
156Urinary IncontinenceFAERS: 5US FAERS
157Atrial FibrillationFAERS: 4US FAERS
158Blood albumin decreasedFAERS: 4US FAERS
159Blood glucose decreasedFAERS: 4US FAERS
160Cancer PainFAERS: 4US FAERS
161CytopeniaFAERS: 4US FAERS
162Extra dose administeredFAERS: 4US FAERS
163Feeling jitteryFAERS: 4US FAERS
164General physical health deteriorationFAERS: 4US FAERS
165Head discomfortFAERS: 4US FAERS
166HerniaFAERS: 4US FAERS
167Inappropriate schedule of drug administrationFAERS: 4US FAERS
168Initial insomniaFAERS: 4US FAERS
169Intentional dose omissionFAERS: 4US FAERS
170Joint stiffnessFAERS: 4US FAERS
171Limb injuryFAERS: 4US FAERS
172Lymphocyte count decreasedFAERS: 4US FAERS
173Oral candidiasisFAERS: 4US FAERS
174Prescribed overdoseFAERS: 4US FAERS
175SciaticaFAERS: 4US FAERS
176StressFAERS: 4US FAERS
177SwellingFAERS: 4US FAERS
178ThrombosisFAERS: 4US FAERS
179Tooth ExtractionFAERS: 4US FAERS
180Upper-airway cough syndromeFAERS: 4US FAERS
181Acute kidney injuryFAERS: 3US FAERS
182AgitationFAERS: 3US FAERS
183Allergic sinusitisFAERS: 3US FAERS
184Angular cheilitisFAERS: 3US FAERS
185Bladder discomfortFAERS: 3US FAERS
186Blood chloride decreasedFAERS: 3US FAERS
187Blood creatinine abnormalFAERS: 3US FAERS
188Blood potassium increasedFAERS: 3US FAERS
189Clostridium difficile colitisFAERS: 3US FAERS
190ConjunctivitisFAERS: 3US FAERS
191Disease recurrenceFAERS: 3US FAERS
192DisorientationFAERS: 3US FAERS
193FolliculitisFAERS: 3US FAERS
194Gastrointestinal viral infectionFAERS: 3US FAERS
195GlossitisFAERS: 3US FAERS
196Hospice CareFAERS: 3US FAERS
197Imaging procedure abnormalFAERS: 3US FAERS
198Incision site painFAERS: 3US FAERS
199Incisional herniaFAERS: 3US FAERS
200Increased upper airway secretionFAERS: 3US FAERS
201Intestinal PerforationFAERS: 3US FAERS
202LethargyFAERS: 3US FAERS
203Motion SicknessFAERS: 3US FAERS
204Muscle strainFAERS: 3US FAERS
205Oral fungal infectionFAERS: 3US FAERS
206Pelvic PainFAERS: 3US FAERS
207Product solubility abnormalFAERS: 3US FAERS
208PsoriasisFAERS: 3US FAERS
209Pulmonary congestionFAERS: 3US FAERS
210Rash erythematousFAERS: 3US FAERS
211RegurgitationFAERS: 3US FAERS
212Sinus headacheFAERS: 3US FAERS
213Terminal stateFAERS: 3US FAERS
214Therapy non-responderFAERS: 3US FAERS
215ThirstFAERS: 3US FAERS
216TinnitusFAERS: 3US FAERS
217Abdominal massFAERS: 2US FAERS
218AcneFAERS: 2US FAERS
219AgeusiaFAERS: 2US FAERS
220Alanine aminotransferase decreasedFAERS: 2US FAERS
221Ankle FractureFAERS: 2US FAERS
222Ankylosing spondylitisFAERS: 2US FAERS
223Anorectal discomfortFAERS: 2US FAERS
224AsthmaFAERS: 2US FAERS
225Back disorderFAERS: 2US FAERS
226Bladder painFAERS: 2US FAERS
227Blood creatinine decreasedFAERS: 2US FAERS
228Blood glucose fluctuationFAERS: 2US FAERS
229Blood urine presentFAERS: 2US FAERS
230Bowel movement irregularityFAERS: 2US FAERS
231Breast discomfortFAERS: 2US FAERS
232BronchospasmFAERS: 2US FAERS
233CheilitisFAERS: 2US FAERS
234DiscomfortFAERS: 2US FAERS
235Disease ProgressionFAERS: 2US FAERS
236Drug therapeutic incompatibilityFAERS: 2US FAERS
237Emotional disorderFAERS: 2US FAERS
238Emotional distressFAERS: 2US FAERS
239External ear painFAERS: 2US FAERS
240Eye irritationFAERS: 2US FAERS
241Eye painFAERS: 2US FAERS
242Failure to ThriveFAERS: 2US FAERS
243Feeling of body temperature changeFAERS: 2US FAERS
244Food aversionFAERS: 2US FAERS
245Full blood count decreasedFAERS: 2US FAERS
246Gastrointestinal PainFAERS: 2US FAERS
247Gastrointestinal hypomotilityFAERS: 2US FAERS
248Gastrointestinal motility disorderFAERS: 2US FAERS
249Gastrointestinal sounds abnormalFAERS: 2US FAERS
250HaematotoxicityFAERS: 2US FAERS
251Hip surgeryFAERS: 2US FAERS
252HordeolumFAERS: 2US FAERS
253HyperacusisFAERS: 2US FAERS
254HypervigilanceFAERS: 2US FAERS
255Impaired gastric emptyingFAERS: 2US FAERS
256Increased tendency to bruiseFAERS: 2US FAERS
257InflammationFAERS: 2US FAERS
258Intestinal FistulaFAERS: 2US FAERS
259Lymphocyte count increasedFAERS: 2US FAERS
260LymphomaFAERS: 2US FAERS
261MalnutritionFAERS: 2US FAERS
262Medication residue presentFAERS: 2US FAERS
263Mental status changesFAERS: 2US FAERS
264MetastasisFAERS: 2US FAERS
265Muscle tightnessFAERS: 2US FAERS
266Myocardial InfarctionFAERS: 2US FAERS
267Noninfective gingivitisFAERS: 2US FAERS
268OnychoclasisFAERS: 2US FAERS
269OnychomycosisFAERS: 2US FAERS
270PallorFAERS: 2US FAERS
271Pelvic discomfortFAERS: 2US FAERS
272Pelvic massFAERS: 2US FAERS
273Pericardial effusionFAERS: 2US FAERS
274Peritoneal lesionFAERS: 2US FAERS
275PhotophobiaFAERS: 2US FAERS
276Physical deconditioningFAERS: 2US FAERS
277Poor peripheral circulationFAERS: 2US FAERS
278Positron emission tomogram abnormalFAERS: 2US FAERS
279Product label issueFAERS: 2US FAERS
280Product packaging quantity issueFAERS: 2US FAERS
281Protein total decreasedFAERS: 2US FAERS
282Red cell distribution width decreasedFAERS: 2US FAERS
283RhinitisFAERS: 2US FAERS
284Secretion dischargeFAERS: 2US FAERS
285SepsisFAERS: 2US FAERS
286Skin lesionFAERS: 2US FAERS
287Solar lentigoFAERS: 2US FAERS
288Tongue blisteringFAERS: 2US FAERS
289TrismusFAERS: 2US FAERS
290Upper respiratory tract congestionFAERS: 2US FAERS
291Urinary RetentionFAERS: 2US FAERS
292Uterine spasmFAERS: 2US FAERS
293Vaginal DischargeFAERS: 2US FAERS
294Walking aid userFAERS: 2US FAERS
295WheezingFAERS: 2US FAERS
296White blood cell count abnormalFAERS: 2US FAERS
297Wound ComplicationFAERS: 2US FAERS
298Activities of daily living impairedFAERS: 1US FAERS
299Administration site bruiseFAERS: 1US FAERS
300AgranulocytosisFAERS: 1US FAERS
301Anal abscessFAERS: 1US FAERS
302Anal fistula infectionFAERS: 1US FAERS
303Anaphylactic shockFAERS: 1US FAERS
304AngerFAERS: 1US FAERS
305AnuriaFAERS: 1US FAERS
306AphasiaFAERS: 1US FAERS
307Apparent deathFAERS: 1US FAERS
308AppendicitisFAERS: 1US FAERS
309Atrial FlutterFAERS: 1US FAERS
310Autoimmune colitisFAERS: 1US FAERS
311Autonomic neuropathyFAERS: 1US FAERS
312BedriddenFAERS: 1US FAERS
313Bile output increasedFAERS: 1US FAERS
314Blood alkaline phosphatase decreasedFAERS: 1US FAERS
315Blood bilirubin abnormalFAERS: 1US FAERS
316Blood glucose abnormalFAERS: 1US FAERS
317Blood iron increasedFAERS: 1US FAERS
318Blood lactate dehydrogenase decreasedFAERS: 1US FAERS
319Blood lactate dehydrogenase increasedFAERS: 1US FAERS
320Blood magnesium abnormalFAERS: 1US FAERS
321Blood phosphorus decreasedFAERS: 1US FAERS
322Blood phosphorus increasedFAERS: 1US FAERS
323Blood potassium abnormalFAERS: 1US FAERS
324Blood sodium increasedFAERS: 1US FAERS
325Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
326Blood urea abnormalFAERS: 1US FAERS
327Bone marrow toxicityFAERS: 1US FAERS
328BradycardiaFAERS: 1US FAERS
329Brain natriuretic peptide increasedFAERS: 1US FAERS
330Bronchial irritationFAERS: 1US FAERS
331Capillary FragilityFAERS: 1US FAERS
332Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
333Carbon dioxide increasedFAERS: 1US FAERS
334Central nervous system lesionFAERS: 1US FAERS
335Cerebral disorderFAERS: 1US FAERS
336ClumsinessFAERS: 1US FAERS
337Complication associated with deviceFAERS: 1US FAERS
338Compression fractureFAERS: 1US FAERS
339Contrast media reactionFAERS: 1US FAERS
340Creatinine renal clearance increasedFAERS: 1US FAERS
341CryingFAERS: 1US FAERS
342Dark circles under eyesFAERS: 1US FAERS
343Deep Vein ThrombosisFAERS: 1US FAERS
344Dermatitis acneiformFAERS: 1US FAERS
345Device related infectionFAERS: 1US FAERS
346Drug administration errorFAERS: 1US FAERS
347DysarthriaFAERS: 1US FAERS
348DyspareuniaFAERS: 1US FAERS
349EczemaFAERS: 1US FAERS
350EnteritisFAERS: 1US FAERS
351Enterococcal sepsisFAERS: 1US FAERS
352EnuresisFAERS: 1US FAERS
353Exfoliative rashFAERS: 1US FAERS
354Food PoisoningFAERS: 1US FAERS
355FractureFAERS: 1US FAERS
356Full blood count abnormalFAERS: 1US FAERS
357Gait inabilityFAERS: 1US FAERS
358Gastric ulcerFAERS: 1US FAERS
359Gastrointestinal perforationFAERS: 1US FAERS
360Gastrostomy tube site complicationFAERS: 1US FAERS
361GastrostomyFAERS: 1US FAERS
362GingivitisFAERS: 1US FAERS
363Gluten sensitivityFAERS: 1US FAERS
364Hepatic enzyme decreasedFAERS: 1US FAERS
365HepatitisFAERS: 1US FAERS
366HepatotoxicityFAERS: 1US FAERS
367HungerFAERS: 1US FAERS
368HyperkeratosisFAERS: 1US FAERS
369HypothyroidismFAERS: 1US FAERS
370IleusFAERS: 1US FAERS
371Inappropriate schedule of product administrationFAERS: 1US FAERS
372Incorrect route of drug administrationFAERS: 1US FAERS
373Incorrect route of product administrationFAERS: 1US FAERS
374Influenza virus test positiveFAERS: 1US FAERS
375Injection site pruritusFAERS: 1US FAERS
376Intestinal metastasisFAERS: 1US FAERS
377Iron OverloadFAERS: 1US FAERS
378Irregular sleep phaseFAERS: 1US FAERS
379Lacrimation decreasedFAERS: 1US FAERS
380Lactose IntoleranceFAERS: 1US FAERS
381Lipase increasedFAERS: 1US FAERS
382Lymph node abscessFAERS: 1US FAERS
383Lymph node palpableFAERS: 1US FAERS
384Lymph nodes scan abnormalFAERS: 1US FAERS
385Lymphocyte percentage increasedFAERS: 1US FAERS
386Macular degenerationFAERS: 1US FAERS
387MaculeFAERS: 1US FAERS
388Magnesium DeficiencyFAERS: 1US FAERS
389MalabsorptionFAERS: 1US FAERS
390Malignant ascitesFAERS: 1US FAERS
391Malignant gastrointestinal obstructionFAERS: 1US FAERS
392Medical procedureFAERS: 1US FAERS
393Medication ErrorFAERS: 1US FAERS
394Metastases to abdominal cavityFAERS: 1US FAERS
395Migraine with AuraFAERS: 1US FAERS
396Monocyte count increasedFAERS: 1US FAERS
397Mouth swellingFAERS: 1US FAERS
398Multiple SclerosisFAERS: 1US FAERS
399Nail pigmentationFAERS: 1US FAERS
400No adverse eventFAERS: 1US FAERS
401NocturiaFAERS: 1US FAERS
402Non-cardiac chest painFAERS: 1US FAERS
403Nuclear magnetic resonance imaging breast abnormalFAERS: 1US FAERS
404NystagmusFAERS: 1US FAERS
405ObesityFAERS: 1US FAERS
406ObstructionFAERS: 1US FAERS
407Ocular icterusFAERS: 1US FAERS
408OnycholysisFAERS: 1US FAERS
409Oral viral infectionFAERS: 1US FAERS
410Oropharyngeal discomfortFAERS: 1US FAERS
411OsteoporosisFAERS: 1US FAERS
412Ovarian enlargementFAERS: 1US FAERS
413OverdoseFAERS: 1US FAERS
414Pain of skinFAERS: 1US FAERS
415Pancreatic carcinoma recurrentFAERS: 1US FAERS
416Pancreatic enzymes abnormalFAERS: 1US FAERS
417ParacentesisFAERS: 1US FAERS
418ParesisFAERS: 1US FAERS
419Performance status decreasedFAERS: 1US FAERS
420PeriarthritisFAERS: 1US FAERS
421PetechiaeFAERS: 1US FAERS
422PneumothoraxFAERS: 1US FAERS
423Product administration errorFAERS: 1US FAERS
424Product dispensing errorFAERS: 1US FAERS
425Product physical issueFAERS: 1US FAERS
426Product prescribing issueFAERS: 1US FAERS
427Product taste abnormalFAERS: 1US FAERS
428Pseudomyxoma PeritoneiFAERS: 1US FAERS
429Pulmonary EmbolismFAERS: 1US FAERS
430Quality of life decreasedFAERS: 1US FAERS
431Reflux gastritisFAERS: 1US FAERS
432Rehabilitation therapyFAERS: 1US FAERS
433Renal painFAERS: 1US FAERS
434Respiratory FailureFAERS: 1US FAERS
435Restless Legs SyndromeFAERS: 1US FAERS
436Retinal DetachmentFAERS: 1US FAERS
437Scan abnormalFAERS: 1US FAERS
438Sensitive skinFAERS: 1US FAERS
439Sexual DysfunctionFAERS: 1US FAERS
440ShockFAERS: 1US FAERS
441Skin UlcerFAERS: 1US FAERS
442Somatic symptom disorderFAERS: 1US FAERS
443Squamous cell carcinomaFAERS: 1US FAERS
444Stomach scan abnormalFAERS: 1US FAERS
445TachyphreniaFAERS: 1US FAERS
446Thrombosis in deviceFAERS: 1US FAERS
447Time perception alteredFAERS: 1US FAERS
448Tongue discomfortFAERS: 1US FAERS
449Tooth InfectionFAERS: 1US FAERS
450Tooth LossFAERS: 1US FAERS
451Transaminases increasedFAERS: 1US FAERS
452Troponin increasedFAERS: 1US FAERS
453UlcerFAERS: 1US FAERS
454Umbilical herniaFAERS: 1US FAERS
455Ureteral stent insertionFAERS: 1US FAERS
456Urine cannabinoids increasedFAERS: 1US FAERS
457Urine flow decreasedFAERS: 1US FAERS
458Vascular wall hypertrophyFAERS: 1US FAERS
459Venous occlusionFAERS: 1US FAERS
460Vessel puncture site bruiseFAERS: 1US FAERS
461cancer surgeryFAERS: 1US FAERS
462furuncleFAERS: 1US FAERS
463jaundiceFAERS: 1US FAERS
464nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.